Order Article Reprints

Taylor JL, Kokolus KM, Basse PH, Filderman JN, Cosgrove CE, Watkins SC, Gambotto A, Lowe DB, Edwards RP, Kalinski P, et al. Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1. Vaccines. 2024; 12(7):777. https://doi.org/10.3390/vaccines12070777

Taylor, Jennifer L., Kathleen M. Kokolus, Per H. Basse, Jessica N. Filderman, Chloe E. Cosgrove, Simon C. Watkins, Andrea Gambotto, Devin B. Lowe, Robert P. Edwards, Pawel Kalinski, and et al. 2024. "Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1" Vaccines 12, no. 7: 777. https://doi.org/10.3390/vaccines12070777

Taylor, J. L., Kokolus, K. M., Basse, P. H., Filderman, J. N., Cosgrove, C. E., Watkins, S. C., Gambotto, A., Lowe, D. B., Edwards, R. P., Kalinski, P., & Storkus, W. J. (2024). Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1. Vaccines, 12(7), 777. https://doi.org/10.3390/vaccines12070777